GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nipro Corp (OTCPK:NPRRF) » Definitions » Equity-to-Asset

Nipro (NPRRF) Equity-to-Asset : 0.22 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Nipro Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Nipro's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $1,690 Mil. Nipro's Total Assets for the quarter that ended in Dec. 2023 was $7,723 Mil. Therefore, Nipro's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.22.

The historical rank and industry rank for Nipro's Equity-to-Asset or its related term are showing as below:

NPRRF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.17   Med: 0.21   Max: 0.25
Current: 0.22

During the past 13 years, the highest Equity to Asset Ratio of Nipro was 0.25. The lowest was 0.17. And the median was 0.21.

NPRRF's Equity-to-Asset is ranked worse than
88.61% of 869 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs NPRRF: 0.22

Nipro Equity-to-Asset Historical Data

The historical data trend for Nipro's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nipro Equity-to-Asset Chart

Nipro Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 0.18 0.19 0.20 0.20

Nipro Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.20 0.21 0.22 0.22

Competitive Comparison of Nipro's Equity-to-Asset

For the Medical Instruments & Supplies subindustry, Nipro's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nipro's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Nipro's Equity-to-Asset falls into.



Nipro Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Nipro's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )=Total Stockholders Equity/Total Assets
=1543.546/7686.413
=0.20

Nipro's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1690.419/7722.513
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nipro  (OTCPK:NPRRF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Nipro Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Nipro's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Nipro (NPRRF) Business Description

Traded in Other Exchanges
Address
3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Nipro (NPRRF) Headlines

No Headlines